Molecular Pharmacology 2014-10-01

Functional selectivity of allosteric interactions within G protein-coupled receptor oligomers: the dopamine D1-D3 receptor heterotetramer.

Xavier Guitart, Gemma Navarro, Estefania Moreno, Hideaki Yano, Ning-Sheng Cai, Marta Sánchez-Soto, Sandeep Kumar-Barodia, Yamini T Naidu, Josefa Mallol, Antoni Cortés, Carme Lluís, Enric I Canela, Vicent Casadó, Peter J McCormick, Sergi Ferré

Index: Mol. Pharmacol. 86(4) , 417-29, (2014)

Full Text: HTML

Abstract

The dopamine D1 receptor-D3 receptor (D1R-D3R) heteromer is being considered as a potential therapeutic target for neuropsychiatric disorders. Previous studies suggested that this heteromer could be involved in the ability of D3R agonists to potentiate locomotor activation induced by D1R agonists. It has also been postulated that its overexpression plays a role in L-dopa-induced dyskinesia and in drug addiction. However, little is known about its biochemical properties. By combining bioluminescence resonance energy transfer, bimolecular complementation techniques, and cell-signaling experiments in transfected cells, evidence was obtained for a tetrameric stoichiometry of the D1R-D3R heteromer, constituted by two interacting D1R and D3R homodimers coupled to Gs and Gi proteins, respectively. Coactivation of both receptors led to the canonical negative interaction at the level of adenylyl cyclase signaling, to a strong recruitment of β-arrestin-1, and to a positive cross talk of D1R and D3R agonists at the level of mitogen-activated protein kinase (MAPK) signaling. Furthermore, D1R or D3R antagonists counteracted β-arrestin-1 recruitment and MAPK activation induced by D3R and D1R agonists, respectively (cross-antagonism). Positive cross talk and cross-antagonism at the MAPK level were counteracted by specific synthetic peptides with amino acid sequences corresponding to D1R transmembrane (TM) domains TM5 and TM6, which also selectively modified the quaternary structure of the D1R-D3R heteromer, as demonstrated by complementation of hemiproteins of yellow fluorescence protein fused to D1R and D3R. These results demonstrate functional selectivity of allosteric modulations within the D1R-D3R heteromer, which can be involved with the reported behavioral synergism of D1R and D3R agonists. U.S. Government work not protected by U.S. copyright.


Related Compounds

  • ADENOSINE 3':5...
  • Coelenterazine
  • Adenosine cyclopho...

Related Articles:

Sinensetin enhances adipogenesis and lipolysis by increasing cyclic adenosine monophosphate levels in 3T3-L1 adipocytes.

2015-01-01

[Biol. Pharm. Bull. 38(4) , 552-8, (2015)]

Suppression of InsP3 receptor-mediated Ca2+ signaling alleviates mutant presenilin-linked familial Alzheimer's disease pathogenesis.

2014-05-14

[J. Neurosci. 34(20) , 6910-23, (2014)]

Prostacyclin receptor expression on platelets of humans with type 2 diabetes is inversely correlated with hemoglobin A1c levels.

2015-01-01

[Prostaglandins Other Lipid Mediat. 116-117 , 131-5, (2015)]

The regions within the N-terminus critical for human glucagon like peptide-1 receptor (hGLP-1R) cell surface expression.

2014-01-01

[Sci. Rep. 4 , 7410, (2014)]

PKA signaling drives mammary tumorigenesis through Src.

2015-02-26

[Oncogene 34(9) , 1160-73, (2015)]

More Articles...